4.5 Article

Association of Thyroid Dysfunction With Cognitive Function An Individual Participant Data Analysis

期刊

JAMA INTERNAL MEDICINE
卷 181, 期 11, 页码 1440-1450

出版社

AMER MEDICAL ASSOC
DOI: 10.1001/jamainternmed.2021.5078

关键词

-

资金

  1. European Commission project THYRAGE [666869]
  2. Swiss National Science Foundation (SNSF) [320030-172676]
  3. National Heart, Lung, and Blood Institute [HHSN268201200036C, HHSN268200800007C, HHSN268201800001C, N01HC55222, N01HC85079, N01HC85080, N01HC85081, N01HC85082, N01HC85083, N01HC85086, 75N92021D00006, U01HL080295, U01HL130114]
  4. National Institute of Neurological Disorders and Stroke
  5. National Institute on Aging [R01AG023629, N01-AG-6-2101, N01-AG-6-2103, N01-AG-6-2106]
  6. National Institute of Nursing Research grant [R01-NR012459]
  7. Intramural Research Program of the NIH National Institute on Aging
  8. Italian Ministry of Health [ICS110.1/RF97.71]
  9. US National Institute on Aging [263MD 9164, 263MD 821336]
  10. Intramural Research Program of the NIH National Institute on Aging, Baltimore, Maryland
  11. Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI09C1379 [A092077]]
  12. Netherlands Ministry of HealthWelfare and Sports, Directorate of Long-Term Care
  13. NIH
  14. National Institute on Aging
  15. National Institute of Arthritis and Musculoskeletal and Skin Diseases
  16. National Center for Advancing Translational Sciences
  17. NIH Roadmap for Medical Research [U01 AG027810, U01 AG042124, U01 AG042139, U01 AG042140, U01 AG042143, U01 AG042145, U01 AG042168, U01 AR066160, UL1 TR000128]
  18. NIH NCATS [UL1TR002369]
  19. Oregon Clinical and Translational Institute
  20. Dutch Kidney Foundation [E.033]
  21. Dutch Alzheimer Foundation
  22. Japanese Ministry of Health, Labour andWelfare
  23. US Department of Energy
  24. German Federal State of Mecklenburg-West Pomerania
  25. [R01AG027058]
  26. [R01AG15928]
  27. [R01AG20098]

向作者/读者索取更多资源

In this study of over 74,000 adults, subclinical hypothyroidism and hyperthyroidism were not found to be associated with cognitive function, cognitive decline, or incident dementia. The role of overt thyroid dysfunction in dementia risk remains inconclusive, and screening for subclinical thyroid dysfunction in older adults for cognitive decline is not supported based on these findings.
IMPORTANCE In clinical guidelines, overt and subclinical thyroid dysfunction are mentioned as causal and treatable factors for cognitive decline. However, the scientific literature on these associations shows inconsistent findings. OBJECTIVE To assess cross-sectional and longitudinal associations of baseline thyroid dysfunction with cognitive function and dementia. DESIGN, SETTING, AND PARTICIPANTS This multicohort individual participant data analysis assessed 114 267 person-years (median, 1.7-11.3 years) of follow-up for cognitive function and 525 222 person-years (median, 3.8-15.3 years) for dementia between 1989 and 2017. Analyses on cognitive function included 21 cohorts comprising 38 144 participants. Analyses on dementia included eight cohorts with a total of 2033 cases with dementia and 44 573 controls. Data analysis was performed from December 2016 to January 2021. EXPOSURES Thyroid function was classified as overt hyperthyroidism, subclinical hyperthyroidism, euthyroidism, subclinical hypothyroidism, and overt hypothyroidism based on uniform thyrotropin cutoff values and study-specific free thyroxine values. MAIN OUTCOMES AND MEASURES The primary outcome was global cognitive function, mostly measured using the Mini-Mental State Examination. Executive function, memory, and dementia were secondary outcomes. Analyses were first performed at study level using multivariable linear regression and multivariable Cox regression, respectively. The studies were combined with restricted maximum likelihood meta-analysis. To overcome the use of different scales, results were transformed to standardized mean differences. For incident dementia, hazard ratios were calculated. RESULTS Among 74 565 total participants, 66 567 (89.3%) participants had normal thyroid function, 577 (0.8%) had overt hyperthyroidism, 2557 (3.4%) had subclinical hyperthyroidism, 4167 (5.6%) had subclinical hypothyroidism, and 697 (0.9%) had overt hypothyroidism. The study-specific median age at baseline varied from 57 to 93 years; 42 847 (57.5%) participants were women. Thyroid dysfunction was not associated with global cognitive function; the largest differences were observed between overt hypothyroidism and euthyroidism-cross-sectionally (-0.06 standardized mean difference in score; 95% CI, -0.20 to 0.08; P = .40) and longitudinally (0.11 standardized mean difference higher decline per year; 95% CI, -0.01 to 0.23; P = .09). No consistent associations were observed between thyroid dysfunction and executive function, memory, or risk of dementia. CONCLUSIONS AND RELEVANCE In this individual participant data analysis of more than 74 000 adults, subclinical hypothyroidism and hyperthyroidism were not associated with cognitive function, cognitive decline, or incident dementia. No rigorous conclusions can be drawn regarding the role of overt thyroid dysfunction in risk of dementia. These findings do not support the practice of screening for subclinical thyroid dysfunction in the context of cognitive decline in older adults as recommended in current guidelines.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据